MedTrace Logo

Acellular Dermal Matrix Allograft Versus Free Gingival Graft

NCT03251001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-03-09

No results posted yet for this study

Summary

The present split-mouth controlled randomized clinical trial aimed to evaluate clinical and histological results of acellular dermal matrix allograft (ADM) compared to autogenous free gingival graft (FGG)

Conditions

  • Gingiva Atrophy
  • Gingivitis

Interventions

PROCEDURE

Control

Free epithelized gingival graft, harvested from palate, was grafted in a site with lack of keratinized gingiva

DEVICE

Acellular Dermal Matrix

Acellular Dermal Matrix was grafted in a site with lack of keratinized gingiva, in substitution of an autogenous graft from patient palate

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-02-01
Primary Completion
2017-11-30
Completion
2017-12-20

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03251001 on ClinicalTrials.gov